+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
PTC Therapeutics - logo

PTC Therapeutics is a biopharmaceutical company that focuses on the development and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. The company's lead product candidate is Translarna (ataluren), which is for the treatment of of nonsense mutation Duchenne muscular dystrophy in ambulatory patients. It is currently in Phase III clinical trials to treat cystic fibrosis caused by nonsense mutations. The company was founded in 1998 and is headquartered in South Plainfield, New Jersey.

North America Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

North America Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 86 Pages
  • North America
From
Phenylketonuria Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Phenylketonuria Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • September 2022
  • 69 Pages
  • Global
From
Angelman Syndrome - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Angelman Syndrome - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Amyotrophic Lateral Sclerosis (ALS) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis (ALS) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • March 2024
  • 267 Pages
  • Global
From
Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2019-2024 - Product Thumbnail Image

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2019-2024

  • Report
  • March 2024
  • 650 Pages
  • Global
From
Dravet Syndrome Market Insights, Epidemiology, and Market Forecast - 2030 - Product Thumbnail Image

Dravet Syndrome Market Insights, Epidemiology, and Market Forecast - 2030

  • Report
  • July 2020
  • 143 Pages
  • Global
From
Global Pediatric Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Global Pediatric Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 119 Pages
  • Global
From
Combination Product Services Market by Type of Device Service Focus Area, Company Size, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Combination Product Services Market by Type of Device Service Focus Area, Company Size, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • August 2022
  • 212 Pages
  • Global
From
Biopharmaceutical Contract Manufacturing Market by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022 - 2035 - Product Thumbnail Image

Biopharmaceutical Contract Manufacturing Market by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022 - 2035

  • Report
  • September 2022
  • 799 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • March 2024
  • 1000 Pages
  • Global
From
Global Rare Disease Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Rare Disease Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Cystic Fibrosis Devices - Global Strategic Business Report - Product Thumbnail Image

Cystic Fibrosis Devices - Global Strategic Business Report

  • Report
  • April 2024
  • 93 Pages
  • Global
From
Diffuse Intrinsic Pontine Glioma - Pipeline Insight, 2024 - Product Thumbnail Image

Diffuse Intrinsic Pontine Glioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Glioma - Pipeline Insight, 2024 - Product Thumbnail Image

Glioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 450 Pages
  • Global
From
Rett Syndrome - Pipeline Review, H2 2020 - Product Thumbnail Image

Rett Syndrome - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 178 Pages
  • Global
From
Diabetic Gastroparesis - Pipeline Review, H2 2020 - Product Thumbnail Image

Diabetic Gastroparesis - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 68 Pages
  • Global
From
High-Grade Glioma - Pipeline Insight, 2024 - Product Thumbnail Image

High-Grade Glioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
Global Rare Disease Treatment Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Thumbnail Image

Global Rare Disease Treatment Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • February 2024
  • 220 Pages
  • Global
From
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 90 Pages
  • Global
From
Loading Indicator